Suppression of rat bone marrow cells by friend murine leukemia virus envelope proteins

Virology

Volumn 242, Issue 2, 1998, Pages 357-365

  Mazgareanu, Stefan ^a   Müller, Justus G ^a   Czub, Stefanie ^a   Schimmer, Simone ^a   Bredt, Martin ^a   Czub, Markus ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; MACROPHAGE; MONOCYTE; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; RAT; VIRUS CELL INTERACTION;

ANIMALIA; FRIEND MURINE LEUKEMIA VIRUS; MURINAE; MURINE LEUKEMIA VIRUS; RNA VIRUSES;

EID: 0032520601     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8998     Document Type: Article

References (43)

1. Belli B., Fan H. The leukemogenic potential of an enhancer variant of moloney murine leukemia virus varies with the route of inoculation. J. Virol. 68:1994;6883-6889.
2. Bigda J., Beletsky I., Brakebush C., Varfolomeev Y., Engelmann H., Bigda J., Holtmann H., Wallach D. Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J. Exp. Med. 180:1994;445-460.
3. Buckheit R. W., Bolognesi D. P., Weinhold K. J. The effects of leukemosuppressive immunotherapy on bone marrow infectious cell centers in AKR mice. Virology. 157:1987;387-396.
4. Buckheit R. W., Kurtzberg J., Bolognesi D. P., Weinhold K. J. The coenrichment of stem cells, prothymocytes, and stromal elements with ecotropic retrovirus-producing cells from the bone marrow of leukemia-prone AKR mice. Virology. 162:1988;354-361.
5. Clouse K. A., Cosentino M. L., Weih K. A., Pyle S. W., Robbins P. B., Hochstein H. D., Natarjan V., Farrar W. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J. Immunol. 147:1991;2892-2901.
6. Czub M., Czub S., McAtee F. J., Portis J. L. Age-dependent resistance to murine retrovirus-induced spongiform neurodegeneration results from central nervous system-specific restriction of virus replication. J. Virol. 65:1991;2539-2544.
7. Czub M., Czub S., Rappold M., Mazgareanu S., Schwender S., Demuth M., Hein A., Dörries R. Murine leukemia virus induced neurodegeneration of rats: Enhancement of neuropathogenicity correlates with enhanced viral tropism for macrophages, microglia, and brain vascular cells. Virology. 214:1995;239-244.
8. Dexter T. M., Scott D., Teich N. M. Infection of bone marrow cells in vitro with FLV: Effects on stem cell proliferation, differentiation and leukemogenic capacity. Cell. 12:1977;355-364.
9. Donahue R. E., Johnson M. M., Zon L. I., Clark S. C., Groopman J. E. Suppression ofin vitro. Nature. 326:1987;200-203.
10. Gendelman H. E., Narayan O., Molineaux S., Clements J. E., Ghotbi Z. Slow, persistent replication of lentiviruses: Role of tissue macrophages and macrophage precursors in bone marrow. Proc. Natl. Acad. Sci. USA. 82:1985;7086-7090.
11. Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456-467.
12. Hasenkrug K. J., Robertson S. J., Portis J. L., McAtee F., Nishio J., Chesebro B. Two separate envelope regions influence induction of brain disease by a polytropic murine retrovirus (FMCF98). J. Virol. 70:1996;4825-4828.
13. Heim R., Cubitt A. B., Tsien R. Y. Improved green fluorescence. Nature. 373:1995;664-665.
14. Hein A., Czub S., Xiao L. X., Schwender S., Dörries R., Czub M. Effects of adoptive immune transfers on murine leukemia virus-infection of rats. Virology. 211:1995;408-417.
15. Jacobsen F. W., Rothe M., Rusten L., Goeddel D. V., Smeland E. B., Veiby O. P., Slordal L., Jacobsen S. E. W. Role of the 75-kDa tumor necrosis factor receptor: Inhibition of early hematopoiesis. Proc. Natl. Acad. Sci. USA. 91:1994;10695-10699.
16. Kabat D. Molecular biology of friend viral erythroleukemia. CTMI. 148:1989;1-42.
17. Letarte-Muirhead M., Barclay A. N., Williams A. F. Purification of the Thy-1 molecule, a major cell-surface glycoprotein of rat thymocytes. Biochem. J. 151:1975;685-697.
18. Li Q., Fan H. Combined infection by moloney murine leukemia virus and a mink cell focus-forming virus recombinant induces cytopathic effects in fibroblasts or in long-term bone marrow cultures from preleukemic mice. J. Virol. 64:1990;3701-3711.
19. Linenberger M. L., Abkowitz J. L. Haematological disorders associated with feline retrovirus infections. Baillieres Clin. Haematol. 8:1995;73-112.
20. Lipton S. A., Sucher N. J., Kaiser P. K., Dreyer E. B. Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron. 7:1991;11-118.
21. Maciejewski J. P., Weichold F. F., Young N. S. HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-α J. Immunol. 153:1994;4303-4310.
22. Mandell C. P., Jain N. C., Miller C. J., Dandekar S. Bone marrow monocytes/macrophages are an early cellular target of pathogenic and nonpathogenic isolates of simian immunodeficiency virus (SIVmac) in rhesus macaques. Lab. Invest. 72:1995;323-333.
23. Mason D. W., Williams A. F. The kinetics of antibody binding to membrane antigens in solution and at the cell surface. Biochem. J. 187:1980;1-20.
24. Masuda M., Remington M. P., Hoffman P. M., Ruscetti S. K. Molecular characterization of a neuropathogenic and nonerythroleukemogenic variant of friend murine leukemia virus PVC-211. J. Virol. 66:1992;2798-2806.
25. McElrath M. J., Pruett J. E., Cohn Z. A. Mononuclear phagocytes of blood and bone marrow: Comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc. Natl. Acad. Sci. USA. 86:1989;675-679.
26. Murphy M., Perussia B., Trinchieri G. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells. Exp. Hematol. 16:1988;131-138.
27. Portis J. L., Czub S., Garon C. F., McAtee F. J. Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat andgag-pol. J. Virol. 64:1990;1648-1656.
28. Radosevic K., Garritsen H. S. P., van Graft M., de Grooth B. G., Greve J. A simple and sensitive flow cytometric assay for the determination of the cytotoxic activity of human natural killer cells. J. Immunol. Methods. 135:1990;81-89.
29. Re M. C., Furlini G., Zauli G., La Placa M. Human immunodeficiency virus type 1 (HIV-1) and human hematopoietic progenitor cells. Arch. Virol. 137:1994;1-23.
30. Riekmann P., Poli G., Fox H. C., Kehrl J. H., Fauci A. S. Recombinant gp120 specifically enhances tumor necrosis factor production and IgG secretion from B lymphocytes from HIV-infected individuals but not from seronegative donors. J. Immunol. 147:1991;2992-2927.
31. Robertson M. N., Miyazawa M., Mori S., Caughey B., Evans L., Hayes S. F., Chesebro B. Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: Use in a focal infectivity assay, immunohistochemical studies, electron microscopy and Western blotting. J. Virol. Methods. 34:1991;255-271.
32. Robinson A. P., White T. M., Mason D. W. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology. 57:1986;239-247.
33. Segovia J. C., Bueren J. A., Almendral J. M. Myeloid depression follows infection of susceptible newborn mice with the parvovirus minute virus of mice (Strain i). J. Virol. 69:1995;3229-3232.
34. Siliciano R. F. The role of CD4 in HIV envelope-mediated pathogenesis. CTMI. 206:1996;159-179.
35. Sitbon M., Sola B., Evans L., Nishio J., Hayes S. F., Nathanson K., Garon C. F., Chesebro B. Hemolytic anemia and erythroleukemia, two distinct pathogenic effects of Friend MuLV: mapping of the effects to different regions of the viral genome. Cell. 47:1986;851-859.
36. Spickett G. P., Brandon M. R., Mason D. W., Williams A. F., Woollett G. R. MRC OX-22, a monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leucocyte-common antigen. J. Exp. Med. 158:1983;795-810.
37. Toggas S. M., Masliah E., Rockenstein E. M., Rall G. F., Abraham C. R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 367:1994;188-193.
38. Tse K.-F., Morrow J. K., Hughes N. K., Gallicchio V. S. Stromal cell lines derived from LP-BM5 murine leukemia virus-infected long-term bone marrow cultures impair hematopoiesis in vitro. Blood. 84:1994;1508-1518.
39. van den Brink M. R. M., Herberman R. B., Hiserodt J. C. Generation of natural killer cells from Thy 1.1+ bone marrow precursor cells in the rat. Blood. 1991;2392-2395.
40. Watanabe M., Ringler D. J., Nakamura M., DeLong P. A., Letvin N. L. Simian immunodeficiency virus inhibits bone marrow hematopoietic progenitor cell growth. J. Virol. 64:1990;656-663.
41. Williams A. F. Many cells in the rat bone marrow have cell-surface Thy-1 antigen. Eur. J. Immunol. 6:1976;526-528.
42. Wong P. K. Y., Prasad G., Hansen J., Yuen P. H. ts. Virology. 170:1989;450-459.
43. Young, N. S. 1993, Viruses and Bone Marrow, 16, Hematology. Dekker, New York.